Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to cardiac disorders.
2. Rule 2: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to cardiac disorders.
3. Rule 3: If the molecule contains a halogen atom (-Cl, -Br, -I), it is likely to cause adverse effects related to cardiac disorders.
These rules can be inferred from the given data as follows:
1. Rule 1: The first molecule, CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC 1, contains a nitro group (-NO2). The second molecule, CC1(C2C(C3C(C(=O)C(=C(N)[O-])C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O)O.CC1(C2C(C3C(C(=O)C(=C(N)[O-])C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O)O.[Ca+2] 1, also contains a nitro group (-NO2). The third molecule, C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl 1, contains a nitro group (-NO2). Therefore, all three molecules are likely to cause adverse effects related to cardiac disorders.
2. Rule 2: The first molecule, CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC 1, contains a carbonyl group (-C=O). The second molecule, CC1(C2C(C3C(C(=O)C(=C(N)[O-])C

================================

1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects.
2. Rule 2: The presence of a halogen atom (-Cl, -Br, -I) in a molecule increases the likelihood of causing adverse effects.
3. Rule 3: The presence of a carbonyl group (-C=O) in a molecule increases the likelihood of causing adverse effects.
These rules are based on the analysis of the given data and the observation that molecules with these functional groups are more likely to cause adverse effects. However, it is important to note that these rules are not absolute and there may be other factors that contribute to the adverse effects of a molecule.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to cardiac disorders.
2. Rule 2: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to cardiac disorders.
3. Rule 3: If the molecule contains a benzene ring (C6H5), it is likely to cause adverse effects related to cardiac disorders.
These rules can be inferred from the given data as follows:
1. Rule 1: The molecule with the smiles string "CC(C)CC1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)N1)CC(=O)N)CO)N)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC2=CN=CN2)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)N4CCCC4C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CO)C(=O)NCC(=O)NC(C(C)O)C(=O)N5CCCC5C(=O)N)C(C)O)CO" contains a carboxylic acid group (-COOH), which is known to cause adverse effects related to cardiac disorders.
2. Rule 2: The molecule with the smiles string "CC(C)NCC(C1=CC(=CC(=C1)O)O)O" contains a nitro group (-NO2), which is known to cause adverse effects related to cardiac disorders.
3. Rule 3: The molecule with the smiles string "C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O" contains a benzene ring (C6H5), which is known to cause adverse effects related to cardiac disorders.

================================

1. Rule 1: If the molecule contains a carboxylic acid group, it is likely to cause adverse effects related to cardiac disorders.
2. Rule 2: If the molecule contains a nitro group, it is likely to cause adverse effects related to cardiac disorders.
3. Rule 3: If the molecule contains a benzene ring, it is likely to cause adverse effects related to cardiac disorders.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is more likely to cause adverse effects.
2. Rule 2: If the molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is more likely to cause adverse effects.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is less likely to cause adverse effects.

================================

1. Rule 1: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to cardiac disorders.
2. Rule 2: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to cardiac disorders.
3. Rule 3: If the molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is likely to cause adverse effects related to cardiac disorders.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to cardiac disorders.
2. Rule 2: If the molecule contains a chlorine atom (-Cl), it is likely to cause adverse effects related to cardiac disorders.
3. Rule 3: If the molecule contains a benzene ring (C6H5), it is likely to cause adverse effects related to cardiac disorders.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is more likely to cause adverse effects related to cardiac disorders.
2. Rule 2: If the molecule contains a chlorine atom (Cl), it is more likely to cause adverse effects related to cardiac disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is more likely to cause adverse effects related to cardiac disorders.
These rules can be inferred by analyzing the structures of the molecules and looking for the presence of specific functional groups or atoms that are known to be associated with adverse effects.

================================

1. Rule 1: The presence of a carbonyl group (C=O) in a molecule is a significant indicator of its potential to cause adverse effects.
2. Rule 2: The presence of a nitro group (-NO2) in a molecule is also a significant indicator of its potential to cause adverse effects.
3. Rule 3: The presence of a halogen atom (such as fluorine, chlorine, or bromine) in a molecule is also a significant indicator of its potential to cause adverse effects.
These rules are based on the analysis of the given data and the observation that molecules with these functional groups are more likely to cause adverse effects than molecules without them. However, it is important to note that these rules are not absolute and there may be exceptions to them. Therefore, it is always recommended to consult with a qualified chemist before making any decisions based on these rules.

================================

1. Rule 1: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to cardiac disorders.
2. Rule 2: If a molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is likely to cause adverse effects related to cardiac disorders.
3. Rule 3: If a molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to cardiac disorders.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to cardiac disorders.
2. Rule 2: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to cardiac disorders.
3. Rule 3: If the molecule contains a benzene ring (C6H5), it is likely to cause adverse effects related to cardiac disorders.
These rules can be inferred from the given data as follows:
1. Rule 1: The first molecule, C([C@H]([C@H]([C@@H]([C@H]([C@H](C(=O)O)O)O)O)O)O)O.[Na+].[Fe+3], contains a nitro group (-NO2). The second molecule, CC(=O)N[C@H](COC)C(=O)NCC1=CC=CC=C1, also contains a nitro group (-NO2). The third molecule, [As], contains a nitro group (-NO2). Therefore, all three molecules are likely to cause adverse effects related to cardiac disorders.
2. Rule 2: The fourth molecule, [Na+], contains a carboxylic acid group (-COOH). The fifth molecule, CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl.Cl, also contains a carboxylic acid group (-COOH). The sixth molecule, CN1C2=C(C(=O)N(C1=O)C)NC=N2, contains a carboxylic acid group (-COOH). Therefore, all three molecules are likely to cause adverse effects related to cardiac disorders.
3. Rule 3: The seventh molecule, CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C, contains a benzene ring (C6H5). The eighth molecule, CCCCCC(=O

================================

1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the risk of adverse effects.
2. Rule 2: The presence of a halogen atom (-Cl, -Br, -I) in a molecule increases the risk of adverse effects.
3. Rule 3: The presence of a carbonyl group (-C=O) in a molecule increases the risk of adverse effects.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to cardiac disorders.
2. Rule 2: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to cardiac disorders.
3. Rule 3: If the molecule contains a halogen atom (-Cl, -Br, -I), it is likely to cause adverse effects related to cardiac disorders.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to cardiac disorders.
2. Rule 2: If the molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is likely to cause adverse effects related to cardiac disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to cardiac disorders.

================================

1. Rule 1: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to cardiac disorders.
2. Rule 2: If a molecule contains a chlorine atom (-Cl), it is likely to cause adverse effects related to cardiac disorders.
3. Rule 3: If a molecule contains a benzene ring (C6H5), it is likely to cause adverse effects related to cardiac disorders.

================================

Here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to cardiac disorders.
2. Rule 2: If the molecule contains a chlorine atom (-Cl), it is likely to cause adverse effects related to cardiac disorders.
3. Rule 3: If the molecule contains a benzene ring (C6H5), it is likely to cause adverse effects related to cardiac disorders.
These rules are based on the data provided and can be used to predict whether a new molecule is likely to cause adverse effects related to cardiac disorders.

================================

1. Rule 1: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to cardiac disorders.
2. Rule 2: If a molecule contains a chlorine atom (-Cl), it is likely to cause adverse effects related to cardiac disorders.
3. Rule 3: If a molecule contains a benzene ring (C6H5), it is likely to cause adverse effects related to cardiac disorders.
These rules can be inferred from the given data as follows:
1. Rule 1: The molecule with label 1, "CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)NC3C(OC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)C)CC(=O)O)CO)C(C)CC(=O)O)CC(=O)C4=CC=CC=C4N", contains a nitro group (-NO2). Therefore, it is likely to cause adverse effects related to cardiac disorders.
2. Rule 2: The molecule with label 0, "CC1=C(C=C(C=C1)[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)CC3=CC=C(S3)C4=CC=C(C=C4)F", contains a chlorine atom (-Cl). Therefore, it is likely to cause adverse effects related to cardiac disorders.
3. Rule 3: The molecule with label 1, "C[C@@H](C(=O)N1CC2=CC(=C(C=C2C[C@H]1C(=O)O)OC)OC)N[C@@H](CCC3=CC=CC=C3)C(=O)O", contains a benzene ring (C6H5). Therefore, it is likely to cause adverse effects related to cardiac disorders.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects.
2. Rule 2: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects.
3. Rule 3: If the molecule contains a halogen atom (-F, -Cl, -Br, -I), it is likely to cause adverse effects.

================================

1. Rule 1: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to cardiac disorders.
2. Rule 2: If a molecule contains a chlorine atom, it is likely to cause adverse effects related to cardiac disorders.
3. Rule 3: If a molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to cardiac disorders.

================================

1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects.
2. Rule 2: The presence of a hydroxyl group (-OH) in a molecule increases the likelihood of causing adverse effects.
3. Rule 3: The presence of a chlorine atom (-Cl) in a molecule increases the likelihood of causing adverse effects.

================================

1. Rule 1: The presence of a carbonyl group (C=O) in a molecule is a significant indicator of its potential to cause adverse effects.
2. Rule 2: The presence of a nitro group (-NO2) in a molecule is also a significant indicator of its potential to cause adverse effects.
3. Rule 3: The presence of a halogen atom (such as fluorine, chlorine, or bromine) in a molecule is also a significant indicator of its potential to cause adverse effects.
4. Rule 4: The presence of a hydroxyl group (-OH) in a molecule is a significant indicator of its potential to cause adverse effects.
5. Rule 5: The presence of a sulfur atom (S) in a molecule is also a significant indicator of its potential to cause adverse effects.
6. Rule 6: The presence of a metal ion (such as gold or sodium) in a molecule is also a significant indicator of its potential to cause adverse effects.
7. Rule 7: The presence of a nitrogen atom (N) in a molecule is also a significant indicator of its potential to cause adverse effects.
8. Rule 8: The presence of a carbon-carbon double bond (C=C) in a molecule is a significant indicator of its potential to cause adverse effects.
9. Rule 9: The presence of a carbon-nitrogen double bond (C=N) in a molecule is a significant indicator of its potential to cause adverse effects.
10. Rule 10: The presence of a carbon-oxygen double bond (C=O) in a molecule is a significant indicator of its potential to cause adverse effects.

================================

1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects.
2. Rule 2: The presence of a carbonyl group (-C=O) in a molecule increases the likelihood of causing adverse effects.
3. Rule 3: The presence of a halogen atom (-Cl, -Br, -I) in a molecule increases the likelihood of causing adverse effects.
Explanation:
1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects. This is because nitro groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
2. Rule 2: The presence of a carbonyl group (-C=O) in a molecule increases the likelihood of causing adverse effects. This is because carbonyl groups can react with other molecules to form adducts, which can disrupt cellular processes and lead to toxicity.
3. Rule 3: The presence of a halogen atom (-Cl, -Br, -I) in a molecule increases the likelihood of causing adverse effects. This is because halogen atoms can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects.
2. Rule 2: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects.
3. Rule 3: If the molecule contains a halogen atom (-Cl, -Br, -I), it is likely to cause adverse effects.

================================

1. Rule 1: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to cardiac disorders.
2. Rule 2: If a molecule contains a halogenated aromatic ring, it is likely to cause adverse effects related to cardiac disorders.
3. Rule 3: If a molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to cardiac disorders.
Explanation:
1. The first rule is based on the fact that nitro groups are known to cause adverse effects related to cardiac disorders. Nitro groups can interact with the heart's electrical system and cause arrhythmias, which can lead to heart failure or other serious health problems.
2. The second rule is based on the fact that halogenated aromatic rings are known to cause adverse effects related to cardiac disorders. Halogenated aromatic rings can interact with the heart's electrical system and cause arrhythmias, which can lead to heart failure or other serious health problems.
3. The third rule is based on the fact that carboxylic acid groups are known to cause adverse effects related to cardiac disorders. Carboxylic acid groups can interact with the heart's electrical system and cause arrhythmias, which can lead to heart failure or other serious health problems.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to cardiac disorders.
2. Rule 2: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to cardiac disorders.
3. Rule 3: If the molecule contains a halogen atom (-F, -Cl, -Br, -I), it is likely to cause adverse effects related to cardiac disorders.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects.
2. Rule 2: If the molecule contains a chlorine atom (-Cl), it is likely to cause adverse effects.
3. Rule 3: If the molecule contains a benzene ring (C6H5), it is likely to cause adverse effects.

================================

1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects.
2. Rule 2: The presence of a carboxylic acid group (-COOH) in a molecule increases the likelihood of causing adverse effects.
3. Rule 3: The presence of a halogen atom (-Cl, -Br, -I) in a molecule increases the likelihood of causing adverse effects.
4. Rule 4: The presence of a phenyl group (-C6H5) in a molecule increases the likelihood of causing adverse effects.
5. Rule 5: The presence of a sulfur atom (-S) in a molecule increases the likelihood of causing adverse effects.
6. Rule 6: The presence of a nitrogen atom (-N) in a molecule increases the likelihood of causing adverse effects.
7. Rule 7: The presence of a metal ion (e.g. Ca2+, Na+) in a molecule increases the likelihood of causing adverse effects.
8. Rule 8: The presence of an arsenic atom (-As) in a molecule increases the likelihood of causing adverse effects.
9. Rule 9: The presence of a gadolinium atom (-Gd) in a molecule increases the likelihood of causing adverse effects.
10. Rule 10: The presence of a carbonyl group (-C=O) in a molecule increases the likelihood of causing adverse effects.

================================

1. Rule 1: The molecule with the smiles string "C(C(C(=O)O)S)(C(=O)O)S" is likely to cause adverse effects due to its potential to interact with cardiac receptors. This is because the molecule contains a carboxylic acid group, which is known to interact with cardiac receptors.
2. Rule 2: The molecule with the smiles string "CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)CN.C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to cardiac disorders.
2. Rule 2: If the molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is likely to cause adverse effects related to cardiac disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to cardiac disorders.
These rules can be inferred from the provided data as follows:
1. Rule 1: The molecule with the formula C[NH+](C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=O)C(=C(N)[O-])C1=O)O)[O-])O)N(C)C 1 contains a nitro group (-NO2).
2. Rule 2: The molecule with the formula CC(=O)N(CC(CN(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)C)O)C2=C(C(=C(C(=C2I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I 1 contains a halogen atom (fluorine, chlorine, or bromine).
3. Rule 3: The molecule with the formula C(=N)(N)N 1 contains a carbonyl group (-C=O).

================================

1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects.
2. Rule 2: The presence of a hydroxyl group (-OH) in a molecule increases the likelihood of causing adverse effects.
3. Rule 3: The presence of a chlorine atom (-Cl) in a molecule increases the likelihood of causing adverse effects.
Explanation:
1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects. This is because nitro groups are known to be toxic and can cause oxidative stress, which can lead to tissue damage and other adverse effects.
2. Rule 2: The presence of a hydroxyl group (-OH) in a molecule increases the likelihood of causing adverse effects. This is because hydroxyl groups can react with other molecules to form free radicals, which can cause oxidative stress and lead to tissue damage.
3. Rule 3: The presence of a chlorine atom (-Cl) in a molecule increases the likelihood of causing adverse effects. This is because chlorine atoms can react with other molecules to form free radicals, which can cause oxidative stress and lead to tissue damage.
In the given data, the molecule with the smiles string "C1=CC=C(C=C1)CCCC(=O)OCC(COC(=O)CCCC2=CC=CC=C2)OC(=O)CCCC3=CC=CC=C3" has a nitro group (-NO2) and a hydroxyl group (-OH), and also contains a chlorine atom (-Cl). Therefore, it is likely to cause adverse effects.
The molecule with the smiles string "C1[C@H](CN2[C@@H]1C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C2=O)CC3=CC=CC=C3)CC4=CC=C(C=C4)OCC5=CC=CC=C5)CCCCN)CC6=CNC7=CC=CC=C76)C8=CC=CC=C8)OC(=O)NCCN 1"

================================

